Drug launch timing and international reference pricing - HAL-SHS - Sciences de l'Homme et de la Société Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2013

Drug launch timing and international reference pricing

Résumé

This paper analyzes the timing decisions of pharmaceutical firms to launch a new drug in countries involved in international reference pricing. We show three important features of launch timing when all countries reference the prices in all other countries and in all previous periods of time. First, there is no withdrawal of drugs in any country and in any period of time. Second, there is no strict incentive to delay the launch of a drug in any country. Third, whenever the drug is sold in a country, it is also sold in all countries with larger willingness to pay. We then show that the three results do not hold when the countries only reference a subset of all countries. The first two results do not hold when the reference is on the last period prices only.
Fichier principal
Vignette du fichier
1301.pdf (537.24 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

halshs-00782179 , version 1 (29-01-2013)

Identifiants

  • HAL Id : halshs-00782179 , version 1

Citer

Nicolas Houy, Izabela Jelovac. Drug launch timing and international reference pricing. 2013. ⟨halshs-00782179⟩
189 Consultations
703 Téléchargements

Partager

Gmail Facebook X LinkedIn More